The IAPAC-Lancet HIV Commission seeks to document and summarize experiences and best practices in urban HIV responses, reflecting the diversity of the world’s urban settings and their health successes and challenges in HIV prevention, care, and treatment. The Commission will also address co-morbidities and syndemic conditions associated with HIV. Additionally, the Commission will examine structural and other barriers to achieving Sustainable Development Goal (SDG) 3 and SDG 11 in urban settings. Moreover, the Commission will explore the threat to urban HIV responses posed by the COVID-19 pandemic.
The Commission is structured into seven thematic categories:
- Realizing the Right to Health in Urban Settings
- Building Health Systems Resiliency (Opportunities and Threats)
- Mitigating the Effects of Syndemic Conditions and Co-Morbidities
- Addressing Social Determinants of Health
- Implementing Accountability and Data-Driven Stakeholder Partnerships
- Re-Designing HIV Responses to be Equity-Based
- Modeling the End of Urban HIV Epidemics
The Commission is comprised of representatives from constituencies that form the foundation of urban HIV responses in Fast-Track Cities: elected officials, public health officials, clinical and service providers, and community representatives. Commissioners will be advised by content experts and key opinion leaders in city government administration, health systems, health service delivery, health financing, epidemiology, modeling, human rights, social determinants, implementation science, behavioral and social sciences, and community engagement. Representatives from the three sponsoring institutions – The Lancet HIV, ViiV Healthcare, and the Fast-Track Cities Institute – have appointed ex officio Observers.
Commissioners
José M. Zuniga, PhD, MPH Commission Chair President/CEO, IAPAC Washington, DC, USA |
|
Winnie Byanyima Honorary Commission Co-Chair Executive Director, UNAIDS Geneva, Switzerland |
Shrikala Acharya, MD Project Director, Mumbai District AIDS Control Society Mumbai, India |
|
Jane Anderson, MBBS, PhD Centre for the Study of Sexual Health and HIV, Homerton University London, UK |
|
Geoffrey Barrow, MBBS, PhD, MSc Department of Medicine, University of the West Indies Kingston, Jamaica |
|
Josip Begovac, MD, DPhil Department of Infectious Disease, University of Zagreb Zagreb, Croatia |
|
Elizabeth Bukusi, MBChB, MD, MPH, PhD Chief Researcher, Kenya Medical Research Institute Nairobi, Kenya |
|
Amanda Castel, MD, MPH Professor, George Washington University Washington, DC, USA |
|
Erika Castellanos Director of Programmes, Global Action for Trans Equality (GATE) Amsterdam, The Netherlands |
|
Jorge Cestou, PhD, MBA Director of Program Operations HIV/STI Bureau, Chicago Department of Health Chicago, USA |
|
Dázon Dixon Diallo, MPH, DHL Founder and President, Sister Love Atlanta, USA |
|
Meg Doherty, MD, MPH, PhD Coordinator of Treatment and Care in the Department of HIV/AIDS, WHO Geneva, Switzerland |
|
Ricardo Fuertes Assessor of Education and Social Rights City Council, Education and Social Rights Lisbon, Portugal |
|
Anisha Gandhi, PhD, MPH Acting Assistant Commissioner, Bureau of HIV, NYC Department of Health and Mental Hygiene New York City, USA |
|
Shannon Hader, MD, MPH Deputy Executive Director, Programme, UNAIDS Geneva, Switzerland |
|
Cary James, MA CEO, World Hepatitis Alliance London, UK |
Fran Lawless, MHA Director of the Office of Health Policy and AIDS Funding, Mayor’s Office of Health Policy New Orleans, USA |
|
Jeffrey Lazarus, PhD, MIH, MA Associate Professor, University of Barcelona Barcelona, Spain |
|
Carlos Lobos, MS President, Chile Positivo Santiago, Chile |
|
Alice Pedro Magaia de Abreau, MD, MPH Councilor for Health and Social Affairs, Maputo City Maputo, Mozambique |
|
Nombulelo Magula, MBChB, MSc, PhD Head, Department of Internal Medicine, KwaZulu-Natal University eThekwini, South Africa |
|
Kenneth Mayer, MD Medical Research Director and Co-Chair, Fenway Institute Boston, USA |
|
H. Rodrigo Moheno Secretary General and Co-Founder Fundacion Mexico Vivo Mexico City, Mexico |
|
Mónica Morán-Arribas, MD, MPH Coordinator of HIV Prevention Programme Ministry of Health, Madrid Madrid, Spain |
|
Daniel Nagel CEO, ohhh! foundation Berlin, Germany |
|
Robert Ndugwa, PhD UN-Habitat Nairobi, Kenya |
|
Carol Ngunu, MD, MSc Deputy Director of Health Services, Nairobi City County Department of Health Nairobi, Kenya |
|
Nicoletta Policek, PhD Chair, HIV Scotland Glasgow, UK |
|
Midnight Poonkasetwattana, MSc Executive Director, APCOM Bangkok, Thailand |
|
Olga Rudneva Executive Director Elena Pinchuk ANTIAIDS Foundation Kyiv, Ukraine |
|
Jorge Saavedra, MD, MSc Executive Director, AHF Global Public Health Institute Miami, FL, USA |
|
Lucy Wanjiku Founder and Team Leader, Positive Young Women Voices Nairobi, Kenya |
Advisors
K. Rivet Amico, PhD Associate Professor, Health Behavior & Health Education University of Michigan Ann Arbor, USA |
|
Stefan Baral, MD, MPH Associate Professor in the Department of Epidemiology, Johns Hopkins Baltimore, USA |
|
Donna Futterman, MD Director, Department of Pediatrics Adolescent AIDS Program, Albert Einstein College of Medicine New York, USA |
|
Eleanor Gouws, MSc, MPH, PhD Senior Advisor, UNAIDS Geneva, Switzerland |
|
Quarraisha Abdool Karim, PhD Associate Scientific Director, CAPRISA eThekwini, South Africa |
|
Salim Abdool Karim, MBChB, PhD Director, CAPRISA eThekwini, South Africa |
|
James McIntyre, MBChB Executive Director, Anova Health Institute Johannesburg, South Africa |
|
Greg Millett, MPH amFAR Washington, DC, USA |
|
Saiqa Mullick, MBBCh, MSc, MPH, PhD Director of Implementation Science, Wits Reproductive Health & HIV Institute Johannesburg, South Africa |
|
Brian Williams, PhD Founder, SACEMA Geneva, Switzerland |
Observers
Matthew Halse, PhD Director, Global Public Health ViiV Healthcare |
|
Peter Hayward, MSc Editor, The Lancet HIV |
|
Nanlesta Pilgrim, PhD, MPH Director, Global Implementation Science ViiV Healthcare |